Insmed Incorporated <INSM.O>: BofA Global Research cuts price objective to $209.00 from $214.00
INSM•Related News
Mastercard completes acquisition of stablecoin infrastructure provider BVNK
MA•
Saba Capital Income & Opportunities Fund II declares monthly dividend of $0.058 per share
SABA•
Booking Holdings updates financial calendar with Q2 earnings release, conference call
BKNG•
Concentrix set to speak at Ai4 2026 conference in Las Vegas
CNXC•
Integer Holdings Corporation <ITGR.N>: KeyBanc cuts to sector weight from overweight
ITGR•